Primary Resistance to Gefitinib in a Patient with Lung Adenocarcinoma Harboring an EGFR Exon 19 L747-A750 > P Mutation
This study is the first to report a patient with lung adenocarcinoma harboring an EGFR Ex19Del mutant L747-A750>P who presented with primary resistance to gefitinib.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Qiang Wei, Jin Zhang, Dongsheng Chen, Si Li, Yuanhua Liu Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | China Health | Lung Cancer | Non-Small Cell Lung Cancer | Study